Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Cara Therapeutics Inc.

    NASDAQ: CARA · Real-Time Price · USD
    5.32
    -0.14 (-2.56%)
    At close: Apr 15, 2025, 3:59 PM

    Cara Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 7.14M 20.97M 41.87M 23.03M
    Cost of Revenue
    		 620K 6.17M 7.27M 1.55M
    Gross Profit
    		 6.52M 14.54M 34.6M 21.47M
    Operating Income
    		 -58.38M -121.5M -87.53M -89.08M
    Interest Income
    		 n/a n/a 2.06M 603K
    Pretax Income
    		 -71.27M -118.51M -85.47M -88.44M
    Net Income
    		 -70.87M -118.51M -83.41M -88.19M
    Selling & General & Admin
    		 26.39M 27.65M 30.26M 29.41M
    Research & Development
    		 32.8M 108.51M 91.88M 82.7M
    Other Expenses
    		 5.71M n/a n/a 642K
    Operating Expenses
    		 64.9M 136.29M 122.14M 112.11M
    Interest Expense
    		 8.47M 604K n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 65.52M 142.46M 129.4M 112.11M
    Income Tax Expense
    		 -398K n/a -2.06M -248K
    Shares Outstanding (Basic)
    		 45.63M 54.12M 53.65M 50.72M
    Shares Outstanding (Diluted)
    		 45.63M 54.15M 53.65M 50.72M
    EPS (Basic)
    		 -1.55 -2.19 -1.55 -1.74
    EPS (Diluted)
    		 -1.55 -2.19 -1.55 -1.74
    EBITDA
    		 -62.6M -117.65M -83.8M -88.19M
    EBIT
    		 -62.79M -117.91M -85.47M -88.44M
    Depreciation & Amortization
    		 192K 259K 1.67M 1.55M

    Add to Watchlist